Dietary salt and hypertension: A scientific issue or a matter of faith?

Journal of Evaluation in Clinical Practice

Volumn 9, Issue 1, 2003, Pages 1-22

  Robertson, J Ian S ^a,b,c  

^a WESTERN INFIRMARY   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Elmbank   (United Kingdom)

Author keywords

Body sodium content; Cardiovascular disease

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADENOMA; AGE; AGE DISTRIBUTION; ALDOSTERONE RELEASE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY COMPOSITION; CLINICAL TRIAL; DIET THERAPY; ESSENTIAL HYPERTENSION; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LIFESTYLE; META ANALYSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SALT INTAKE; SODIUM EXCRETION; SODIUM RESTRICTION; SODIUM URINE LEVEL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANIMALS; DIET, SODIUM-RESTRICTED; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; RISK ASSESSMENT; SODIUM; SODIUM CHLORIDE, DIETARY;

EID: 0037322436     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.2003.00359.x     Document Type: Review

References (151)

1. Alderman M.H. & Lamport B. (1990) Moderate sodium restriction: do the benefits justify the hazards? American Journal of Hypertension 3, 499-504.
2. Alderman M.H., Madhaven S., Ooi W.L., Cohen H., Sealey J.E. & Laragh J.H. (1991) Association of the reninsodium profile with the risk of myocardial infarction in patients with hypertension. New England Journal of Medicine 324, 1098-1104.
3. Alderman M.H., Madhaven S., Cohen H., Sealey J.E. & Laragh J.H. (1995) Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 25, 1144-1152.
4. Alderman M.H. & Laragh J.H. (1996) Low urinary sodium and myocardial infarction. Hypertension 27, 156-157.
5. Alderman M.H., Cohen H. & Madhaven S. (1998a) Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES). Lancet 351, 781-785.
6. Alderman M.H., Madhaven S., Cohen H., Sealey J.E. & Laragh J.H. (1998b) Dietary sodium intake and mortality: NHANES. Lancet 351, 988.
7. Alderman M.H., Cohen H. & Madhaven S. (1998c) Sodium intake and mortality. Lancet 351, 1509-1510.
8. Altman D.G. & Hill I.D. (1985) Misleading paper about misleading statistics. Lancet i, 927.
9. Ames R.P. (2001) The effect of sodium supplementation on glucose tolerance and insulin concentrations in patients with hypertension and diabetes mellitus. American Journal of Hypertension 14, 653-659.
10. Antonios T.F.T & MacGregor G.A. (1996) Salt - more adverse effects. Lancet 348, 250-251.
11. Ascherio A., Rimm E.B., Hernán M.A., Giovannucci L., Kawachi I., Stampfer M.J. & Willett W.C. (1998) Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 98, 1198-1204.
12. Bartlett C., Hooper L. & Ebrahim S. (2001) Dietary sodium and blood pressure. New England Journal of Medicine 344, 1717-1718.
13. Beevers D.G. (2001) Salt and cardiovascular disease: not just hypertension. Journal of Human Hypertension 15, 749-750.
14. Beretta-Piccoli C., Davies D.L., Boddy K. et al. (1982) Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clinical Science 63, 257-270.
15. Beretta-Piccoli C., Davies D.L., Brown J.J. et al. (1983) Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. Journal of Hypertension 1, 197-205.
16. Beretta-Piccoli C., Weidmann P., Brown J.J., Davies D.L., Lever A.F. & Robertson J.I.S. (1984) Body sodium blood volume state in essential hypertension: abnormal relation of exchangeable sodium to age and blood pressure in male patients. Journal of Cardiovascular Pharmacology 6 (Suppl. 1), 134-142.
17. Boddy K., Brown J.J., Davies D.L., Elliott A., Harvey I., Haywood J.K., Holloway I., Lever A.F., Robertson J.I.S. & Williams E.D. (1978) Concurrent estimation of total body and exchangeable body sodium in hypertension. Clinical Science 54, 187-191.
18. British Medical Journal (1996) 312, 18 May, passim.
19. British Medical Journal (1997) 315, 23 August, passim.
20. Brown J.J., Düsterdieck G., Fraser R., Lever A.F., Robertson J.I.S., Tree M. & Weir R.J. (1971) Hypertension and chronic renal failure. British Medical Bulletin 27, 128-135.
21. Brown J.J., Davies D.L., Lever A.F. & Robertson J.I.S. (1964) Influence of sodium deprivation and loading on the plasma-renin in man. Journal of Physiology 173, 408-419.
22. Brown J.J., Lever A.F., Robertson J.I.S. et al. (1984a) Salt and hypertension. Lancet ii, 456.
23. Brown J.J., Lever A.F., Robertson J.I.S. et al. (1984b) Salt and hypertension. Lancet ii, 1333-1334.
24. Brown W.B., East B.W., McAreavey D., Robertson J.I.S. & Shackleton D.R. (1982) Methods of measuring in vivo total body sodium and exchangeable sodium in rats. Journal of Physiology 329, 65P.
25. Cappuccio EP., Markandu N.D., Carney C., Sagnella G.A. & MacGregor G.A. (1997) Double-blind randomised trial of modest salt restriction in older people. Lancet 350, 850-854.
26. Charlton B.G. (1995) A critique of Geoffrey Rose's 'population strategy' for preventive medicine. Journal of the Royal Society of Medicine 88, 607-610.
27. Cleland J.G.E, Dargie H.J., Robertson I., Robertson J.I.S. & East B.W. (1987) Total body electrolyte composition in heart failure: a comparison with normal subjects and patients with essential hypertension. British Heart Journal 58, 230-238.
28. Connolly C.K. (1996) Conflict of interest. British Medical Journal 313, 1555.
29. Cutler J.A., Follman D. & Allender P.S. (1997) Randomized trials of sodium reduction: an overview. American Journal of Clinical Nutrition 65 (Suppl.), 643-651.
30. Cutler J.A. (1998) Quoted by Taubes (1998), p. 899.
31. Davey Smith G. & Phillips A.N. (1996) Inflation in epidemiology: the proof and measurement of the association between two things' revisited. British Medical Journal 312, 1659-1661.
32. Davey Smith G. & Phillips A.N. (1997) Correction for regression dilution bias in INTERSALT study was misleading. British Medical Journal 315, 485-486.
33. De Leeuw P. & Birkenhäger W.H. (1997) Renal mechanisms of blood pressure regulation: clinical evidence. In Pathophysiology of Hypertension (eds A. Zanchetti & G. Mancia), pp. 784-802. Elsevier, Amsterdam.
34. Dengel D.R., Galecki A.T., Hagberg J.M. & Pratley R.E. (1998) The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. American Journal of Hypertension 11, 1405-1412.
35. Dengel D.R., Brown M.D., Ferrell R.E. & Supiano M.A., (2001) Role of the angiotensin converting enzyme genotype in sodium sensitivity in older hypertensives. American Journal of Hypertension 14, 1178-1184.
36. Denton D., Weisinger R., Mundy N.I. et al. (1995) The effect of increased salt intake on blood pressure of chimpanzees. Nature Medicine 1, 1009-1016.
37. Dimsdale J.E., Ziegler M., Mills P. & Berry C. (1990) Prediction of salt sensitivity. American Journal of Hypertension 3, 429-435.
38. Dyer A.R., Elliott P., Marmot M., Kesteloot H., Stamler R. & Stamler J. (1996) Commentary: strength and importance of the relation of dietary salt to blood pressure. British Medical Journal 312, 1661-1664.
39. Egan B.M., Weder A.B., Petrin J. & Hoffman R.G. (1991) Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men: relation to saltsensitivity status. American Journal of Hypertension 4, 416-421.
40. Egan B.M., Stepniakowski K. & Goodfriend TL. (1994) Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. American Journal of Hypertension 7, 886-893.
41. Eisenhauer A.C., Matthews R.V. & Clugston R. (1991) Renin-sodium profile and the risk of myocardial infarction in patients with hypertension. New England Journal of Medicine 325, 1106.
42. Elliott P., Stamler J., Nichols R., Dyer A.R., Stamler R., Kesteloot H. & Marmot M. (1996) Intersalt revisited: further analyses of 24 hour urinary sodium excretion and blood pressure within and across populations. British Medical Journal 312, 1249-1253.
43. Elliott P. (1997) Lower sodium for all. Lancet 350, 825-826.
44. Engelman K. (1998) Sodium intake and mortality. Lancet 351, 1508-1509.
45. Eysenck H.J. (1994) Meta-analysis and its problems. British Medical Journal 309, 789-792.
46. Fitzsimons J.T. (1993) Renin in thirst and sodium appetite. In The Renin-Angiotensin System (eds J.I.S. Robertson & M.G. Nicholls), pp. 32.1-32.8. Gower/Mosby, London.
47. Folkow B. (1992) Critical review of studies on salt and hypertension. Clinical and Experimental Hypertension A14, 1-14.
48. Forte J.G., Miguel J.M.P., Miguel M.J.P., de Pádua F. & Rose G. (1989) Salt and blood pressure: a community trial. Journal of Human Hypertension 3, 179-184.
49. Fuchs ED., Gus M., Moreira W.D., Moreira L.B., Moraes R.S., Rosito G.A., Sorucco A., Atanázio P. & Machado R. (1997) Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort. Journal of Hypertension 15, 783-792.
50. Fuenmayor N., Moreira E. & Cubeddu L.X. (1998) Salt sensitivity is associated with insulin resistance in hypertension. American Journal of Hypertension 4, 397-402.
51. Gavras H., Brown J.J., Lever A.F., MacAdam R.F. & Robertson J.I.S. (1971) Acute renal failure, renal tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet ii, 19-22.
52. Gavras H., Kremer D., Brown J.J., Gray B., Lever A.F., MacAdam R.F., Medina A., Morton J.J. & Robertson J.I.S. (1975) Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. American Heart Journal 89, 321-332.
53. Geleijnse J.M., Witteman J.C.M., Bak A.A.A., den Breeijen J.H. & Grobbee D.E. (1995) Long-term moderate sodium restriction does not adversely affect the serum HDL/total cholesterol ratio. Journal of Human Hypertension 9, 975-979.
54. Geleijnse J.M., Hofman A., Witteman J.C.M., Hazebroek A.A.J.M., Valkenburg H.A. & Grobbee D.E. (1996) Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 29, 913-917.
55. Gill J.S., Beevers D.G., Zezulka A.V. & Davies P. (1985) Relation between initial blood pressure and its fall with treatment. Lancet i, 567-569.
56. Gomi T., Shibuya Y., Sakurai J., Hirawa N., Hasegawa K. & Ikeda T (1998) Strict dietary sodium reduction worsens insulin sensitivity by increasing sympathetic nervous activity in patients with primary hypertension. American Journal of Hypertension 11, 1048-1055.
57. Graudal N., Galløe A. & Garred P. (1997) Modest salt restriction in older people. Lancet 350, 1702.
58. Graudal N.A., Galløe A.M. & Garred P. (1998) Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a metaanalysis. Journal of the American Medical Association 279, 1383-1391.
59. Graudal N. & Galløe A. (2000) Should dietary salt restriction be a basic component of antihypertensive therapy? Cardiovascular Drugs and Therapy 14, 381-386.
60. Greenland P. (2001) Beating high blood pressure with lowsodium DASH. New England Journal of Medicine 344, 53-55.
61. Grey A., Braatvedt G. & Holdaway I. (1996) Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men. American Journal of Hypertension 9, 317-322.
62. Grobbee D.E. & Hofman A. (1986) Does sodium restriction lower blood pressure? British Medical Journal 293, 27-29.
63. Harrap S.B., Cumming A.D., Davies D.L., Foy C.J.W., Fraser R., Kamitani A., Connor J.M., Lever A.F. & Watt G.C.M. (2000) Glomerular hyperfiltration, high renin, and low extracellular volume in high blood pressure. Hypertension 35, 952-957.
64. Haynes R.B., Harper A.C., Costley S.R., Johnston M., Logan A.G., Flanagan P.T. & Sackett D.L. (1984) Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. Journal of Hypertension 2, 535-539.
65. He J., Ogden L.G., Vupputuri S., Bazzano L.A., Loria C. & Whelton P.K. (1999) Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. Journal of the American Medical Association 282, 2027-2034.
66. He F.J. & MacGregor G.A. (2000) Effect of longer-term modest salt reduction on blood pressure: a meta-analysis of randomised controlled trials. Implications for public health. Journal of Human Hypertension 14, 846-847.
67. He F.J. & MacGregor G.A. (2001) Neonatal salt intake and blood pressure. Lancet 357, 1880.
68. He J., Whelton P.K., Appel L.J., Charleston J. & Klag M.J. (2000) Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 35, 544-549.
69. Hofman A., Hazebroek A. & Valkenburg H.A. (1983) A randomized trial of sodium intake and blood pressure in newborn infants. Journal of the American Medical Association 250, 370-373.
70. Hooper L., Bartlett C., Davey Smith G. & Ebrahim S. (2002) Systemic review of long-term effects of advice to reduce dietary salt in adults. British Medical Journal 325, 628-632.
71. Hovell M.F. (1982) The experimental evidence for weight loss treatment of essential hypertension: a critical review. American Journal of Public Health 72, 359-368.
72. Intersalt Cooperative Research Group (1988) Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. British Medical Journal 297, 319-328.
73. Johnson R.J., Herrera-Acosta J., Schreiner G.F. & Rodriguez-Iturbe B. (2002) Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. New England Journal of Medicine 346, 913-923.
74. Jones D.W. & Granger J.P. (1999) Sodium and blood pressure. American Heart Association High Blood Pressure Research Newsletter Fall, 23-25.
75. Kaplan N.M. (2000) Evidence in favor of moderate dietary sodium reduction. American Journal of Hypertension 13, 8-13.
76. Karppanen H. & Mervaala E. (1998) Sodium intake and mortality. Lancet 351, 1509.
77. Khaw K.T. & Barrett-Connor E. (1990) Increasing sensitivity of blood pressure to dietary sodium and potassium with increasing age. American Journal of Hypertension 3, 505-511.
78. Kremer D., Lindop G., Brown W.C.B., Morton J.J. & Robertson J.I.S. (1981) Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure. Cardiovascular Research 15, 43-46.
79. Lansdown R. (1993) Streetwise health: the press and the people. Journal of the Royal Society of Medicine 86, 367-368.
80. Law M.R., Frost C.D. & Wald N.J. (1991) Analysis of data from trials of salt reduction. British Medical Journal 302, 819-824.
81. Le Fanu J. (1997) Cross cultural studies such as Intersalt cannot be used to infer causality. British Medical Journal 315, 484.
82. Le Fanu J. (1999) The Rise and Fall of Modern Medicine. Little, Brown, London.
83. McAreavey D., Brown J.J., Cumming A.M.M., Davies D.L., Fraser R., Lever A.F., Mackay A., Morton J.J. & Robertson J.I.S. (1983a) Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis. Journal of Hypertension 1, 297-302.
84. McAreavey D., Cumming A.M.M., Boddy K., Brown J.J., Fraser R., Leckie B.J., Lever A.F., Morton J.J., Robertson J.I.S. & Williams E.D. (1983b) The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives. Clinical Endocrinology 18, 111-118.
85. McCarron D.A. (2001a) Dietary sodium and blood pressure. New England Journal of Medicine 344, 1716-1717.
86. McCarron D.A. (2001b) Sodium excretion and cardiovascular mortality. Lancet 358, 665.
87. MacGregor G.A. (1994) Dietary salt and blood pressure. Lancet 343, 545.
88. MacGregor G. (1996) Low urinary sodium and myocardial infarction. Hypertension 27, 156.
89. MacGregor G.A. (1997) Salt - more adverse effects. American Journal of Hypertension 10 (Suppl.), 37-41.
90. MacGregor G. (1998) TONE shows that lifestyle changes can affect blood pressure. Lancet 351, 886.
91. MacGregor G.A. & de Wardener H.E. (1999) Salt, diet, and health. Lancet 353, 1709-1710.
92. MacGregor G.A. & de Wardener H.E. (2000) 'Salt': a commentary. American Journal of Hypertension 13, 313-316.
93. MacMahon S.W., Macdonald G.J., Bernstein L., Andrews G. & Blacket R.B. (1985) Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet i, 1233-1236.
94. Meltzer J.I. (1996) Low urinary sodium and myocardial infarction. Hypertension 27, 155.
95. Meltzer J.I. (1998) Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine 338, 1696.
96. Mertens T.E. (1993) Estimating the effects of misclassification. Lancet 342, 418-421.
97. Messerli F.H., Schmieder R.E. & Weir M.R. (1997) Salt: a perpetrator of hypertensive target organ disease? Archives of Internal Medicine 157, 2449-2452.
98. Midgley J.P., Matthew A.G., Greenwood C.M.T. & Logan A.G. (1996) Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. Journal of the American Medical Association 275, 1590-1597.
99. Moore T.J., Malarick C., Olmedo A. & Klein R.C. (1991) Salt restriction lowers resting blood pressure but not 24-h ambulatory blood pressure. American Journal of Hypertension 4, 410-415.
100. Morris D. (1965) The Mammals: a Guide to the Living Species. Harper & Row, New York.
101. Nuesch R. & Dieterle T (2000) Industry-sponsored research. Lancet 356, 2193-2194.
102. Overlack A., Ruppert M., Kolloch R., Göbel B., Kraft K., Diehl J., Schmitt W. & Stumpe K.O. (1993) Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 22, 331-338.
103. Overlack A., Ruppert M., Kolloch R., Kraft K. & Stumpe K.O. (1995) Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension. American Journal of Hypertension 8, 829-836.
104. Perry I.K. & Beevers D.G. (1992) Salt intake and stroke: a possible direct effect. Journal of Human Hypertension 6, 23-25.
105. Peto R. (1998) Quoted by Taubes (1998), p. 899.
106. Pettiti D.B. & Freedman D. (2001) Dietary sodium and blood pressure. New England Journal of Medicine 344, 1717.
107. Pomeranz A., Dolfin T., Korzets Z., Eliakim A. & Wolach B. (2002) Increased sodium concentrations in drinking water increase blood pressure in neonates. Journal of Hypertension 20, 203-207.
108. Poulter N.R. (1998) Dietary sodium intake and mortality: NHANES. Lancet 351, 987-988.
109. Reid C.M., Dart A.M., Dewar E.M. & Jennings G.L. (1994) Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. Journal of Hypertension 12, 291-301.
110. Robertson J.I.S. (1984) The renin-aldosterone connection: past, present and future. The Franz Gross Memorial Lecture. Journal of Hypertension 2 (Suppl. 3), 1-14.
111. Robertson J.I.S. (1993) Renin and the pathophysiology of renovascular hypertension. In The Renin-Angiotensin System (eds J.I.S. Robertson & M.G. Nicholls), pp. 55.5-55.34. Gower/Mosby, London.
112. Robertson J.I.S. (1994) Guidelines for the treatment of hypertension: a critical review. Cardiovascular Drugs and Therapy 8, 665-672.
113. Robertson J.I.S. (1997a) Long-term effects of neonatal sodium restriction on blood pressure. American Journal of Hypertension 10, 1425.
114. Robertson J.I.S. (1997b) Hypertension. In Clinical Trials in Cardiology (eds B. Pitt, D. Julian & S. Pocock), pp. 115-160. Saunders, London.
115. Robertson J.I.S. (1997c) Debating nutrition: how strong is the evidence that recommendations to reduce population average salt intake will reduce mortality from cardiovascular disease? Nutrition Bulletin 22, 181-186.
116. Robertson J.I.S. (2000) Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trials. Cardiovascular Drugs and Therapy 14, 357-366.
117. Robertson J.I.S. (2001) A critique of hypertension treatment trials and of their evaluation. Journal of Evaluation in Clinical Practice 7, 149-164.
118. Rose G. (1992) The Strategy of Preventive Medicine. Oxford University Press, Oxford.
119. Ruppert M., Overlack A., Kolloch R., Kraft K., Gobel B. & Stumpe K.O. (1993) Neurohumoral and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. Journal of Hypertension 11, 743-749.
120. Sacks F.M., Svetkey L.P., Vollmer W.M. et al. (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. New England Journal of Medicine 344, 3-10.
121. Schlaich M.P., Klingbeil A.U., Jacobi J., Delles C., Schneider M.P., Schmidt B.M.W. & Schmieder R.E. (2002) Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parenteral history of arterial hypertension. Journal of Hypertension 20, 117-124.
122. Schmieder R.E. (1991) Renin-sodium profile and the risk of myocardial infarction in patients with hypertension. New England Journal of Medicine 325, 1106.
123. Schorr U., Schultz C. & Sharma A.M. (2002) Plasma-renin response to isotonic volume contraction in young salt-sensitive normotensive men. American Journal of Hypertension 15, 48-52.
124. Simpson F.O. (1979) Salt and hypertension: a sceptical review of the evidence. Clinical Science 57 (Suppl.), 463-480.
125. Simpson F.O. (2000) Blood pressure and sodium intake. In Epidemiology of Hypertension. (ed. C.J. Bulpitt), pp. 274-295. Elsevier, Amsterdam.
126. Sinaiko A.R., Gomez-Marin O. & Prineas R.J. (1993) Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension 21, 989-994.
127. Singh R.B., Niaz M.A., Bishnoi U., Begum R. & Rastogi S.S. (1995) Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension. Journal of Human Hypertension 9, 355-362.
128. Singhal A., Cole TJ. & Lucas A. (2001a) Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet 357, 413-419.
129. Singhal A., Cole T.J. & Lucas A. (2001b) Neonatal salt intake and blood pressure. Lancet 357, 1881.
130. Skrabanek P. (1990) Nonsensus consensus. Lancet 335, 1446-1447.
131. Skrabanek P. (1993) The epidemiology of errors. Lancet 342, 1502.
132. Smith W.C.S., Crombie I.K., Tavendale R.T, Gulland S.K. & Tunstall-Pedoe H.D. (1988) Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish heart health study. British Medical Journal 297, 329-330.
133. Staessen J., Bulpitt C.J., Fagard R., Joossens J.V., Lijnen P. & Amery A. (1988) Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. Journal of Hypertension 6, 965-973.
134. Sutton A.J., Abrams K.R. & Jones D.R. (2001) An illustrated guide to the methods of meta-analysis. Journal of Evaluation in Clinical Practice 7, 135-148.
135. Swales J.D. (1991) Dietary salt and blood pressure: the role of meta-analyses. Journal of Hypertension 9 (Suppl. 6), 42-46.
136. Swales J. (1999) Reply to criticisms by MacGregor and de Wardener. Lancet 355, 1710.
137. Taubes G. (1998) The (political) science of salt. Science 281, 898-907.
138. Thompson S.G. & Pocock S.J. (1991) Can meta-analyses be trusted? Lancet 338, 1127-1130.
139. Tian H.G., Guo Z.Y., Hu G., Yu S.J., Sun W., Pietinen P. & Nissinen A. (1995) Changes in sodium intake and blood pressure in a community-based intervention project in China. Journal of Human Hypertension 9, 959-968.
140. Trials of Hypertension Prevention (TOHP) Collaborative Research Group (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure. Archives of Internal Medicine 157, 657-667.
141. Tuck M.L., Sowers J., Dornfield L., Kledzik G. & Maxwell M. (1981) The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. New England Journal of Medicine 304, 930-933.
142. Tunstall-Pedoe H., Woodward M., Tavendale R., A'Brook R. & McCluskey M.K. (1997) Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. British Medical Journal 315, 722-729.
143. Tuomilehto J., Jousilahti P., Rastenyte D., Moltchaniov V., Tanskanen A., Pietinen P. & Nissinen A. (2001) Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 357, 848-851.
144. Van Nueten L., Taylor F.R. & Robertson J.I.S. (1998) Nebivolol versus atenolol and placebo in essential hypertension: a double-blind randomised trial. Journal of Human Hypertension 12, 135-140.
145. Vecchione C., Morisco C., Fratta L., Argenziano L., Trimarco B. & Lembo G. (1998) Dietary sodium restriction impairs endothelial effect of insulin. Hypertension 31, 1261-1265.
146. de Wardener H.E. & Kaplan N.M. (1993) On the assertion that a moderate restriction of sodium intake may have adverse health effects. American Journal of Hypertension 6, 810-814.
147. de Wardener H. & MacGregor G.A. (1998) Sodium intake and mortality. Lancet 351, 1508.
148. de Wardener H.E. (1999) Salt reduction and cardiovascular risk: the anatomy of a myth. Journal of Human Hypertension 13, 1-4.
149. Watt G. (1981) Blood pressure and salt at table. Lancet i, 1205.
150. Webb D.J., Clark S.A., Brown W.B., Fraser R., Lever A.F., Murray G.D. & Robertson J.I.S. (1987) Dietary sodium deprivation raises blood pressure in the rat but does not produce irreversible hyperaldosteronism. Journal of Hypertension 5, 525-531.
151. Whelton P.K., Appel L.J., Espeland M.A. et al. (1998) Sodium reduction and weight loss in the treatment of hypertension in older persons (TONE). Journal of the American Medical Association 279, 839-846.